Showing results (1-10 of 404) with videos related to
Sort By:
Pageof 41
Blood|July 28, 2021
BCL2 and MCL1 inhibitors for hematologic malignanciesAndrew W Roberts, Andrew H Wei, David C S HuangCancer Discovery|August 3, 2019
Polyclonal Heterogeneity: The New Norm for Secondary Clinical Resistance to Targeted Monotherapy in Relapsed Leukemia?Andrew H Wei, Andrew W RobertsHemasphere|June 12, 2023
BCL2 Inhibition: A New Paradigm for the Treatment of AML and BeyondAndrew H Wei, Andrew W RobertsProceedings of the National Academy of Sciences of the United States of America|November 14, 2008
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomasKylie D Mason, Cassandra J Vandenberg, Clare L Scott, et al.Pathology|September 2, 2011
Overcoming blocks in apoptosis with BH3-mimetic therapy in haematological malignanciesSeong Lin Khaw, David C S Huang, Andrew W RobertsPlos Pathogens|January 5, 2011
Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1Marc Kvansakul, Andrew H Wei, Jamie I Fletcher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2017
Venetoclax in Patients with Previously Treated Chronic Lymphocytic LeukemiaAndrew W Roberts, Stephan Stilgenbauer, John F Seymour, et al.Therapeutic Advances in Hematology|February 3, 2016
Current challenges and novel treatment strategies in double hit lymphomasMary Ann Anderson, Alpha Tsui, Meaghan Wall, et al.Cancer Cell|December 12, 2018
BH3-Mimetic Drugs: Blazing the Trail for New Cancer MedicinesDelphine Merino, Gemma L Kelly, Guillaume Lessene, et al.Genome Research|January 10, 2025
Single-cell Rapid Capture Hybridization sequencing reliably detects isoform usage and coding mutations in targeted genesHongke Peng, Jafar S Jabbari, Luyi Tian, et al.Pageof 41